The objective of this study is to evaluate effectiveness and safety of BioMatrix stent in the "real world" daily practice as compared with first-generation drug-eluting stents (sirolimus- or paclitaxel-eluting stents).
This study is a non-randomized, prospective, open-label registry to compare the efficacy and safety of BioMatrix stents versus first-generation drug-eluting stent (DES) in patients with coronary artery disease.
Study Type
OBSERVATIONAL
Enrollment
837
Soon Chun Hyang University Hospital Cheonan
Cheonan, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
composite of death, nonfatal myocardial infarction (MI), or ischemic-driven Target- Vessel Revascularization (TVR)
Time frame: 12 months post procedure
All Death
Time frame: one month
All Death
Time frame: 6 months
All Death
Time frame: yearly upto 5 years
Cardiac death
Time frame: one month
Cardiac death
Time frame: 6 months
Cardiac death
Time frame: yearly upto 5 years
MI
Time frame: one month
MI
Time frame: 6 months
MI
Time frame: yearly upto 5 years
Composite of death or MI
Time frame: one month
Composite of death or MI
Time frame: 6 months
Composite of death or MI
Time frame: yearly upto 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Keimyung University Dongsan Medical Center
Daegu, South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea
Chonnam National University Hospital
Gwangju, South Korea
National Health Insurance Corporation Ilsan Hospital
Ilsan, South Korea
Gachon University Gil Hospital
Incheon, South Korea
Inha University Hospital
Incheon, South Korea
Gyeongsang National University Hospital
Jinju, South Korea
Kwangju Christian Hospital
Kwangju, South Korea
...and 10 more locations
Composite of cardiac death or MI
Time frame: one month
Composite of cardiac death or MI
Time frame: 6 months
Composite of cardiac death or MI
Time frame: yearly upto 5 years
TVR
Time frame: one month
TVR
Time frame: 6 months
TVR
Time frame: yearly upto 5 years
Target-lesion revascularization (TLR)
Time frame: one month
Target-lesion revascularization (TLR)
Time frame: 6 months
Target-lesion revascularization (TLR)
Time frame: yearly upto 5 years
Stent thrombosis (ARC criteria)
Time frame: one month
Stent thrombosis (ARC criteria)
Time frame: 6 months
Stent thrombosis (ARC criteria)
Time frame: yearly upto 5 years
Procedural success defined as achievement of a final diameter stenosis of <30% by visual estimation, without the occurrence of death, Q-wave MI, or urgent revascularization during the index hospitalization
At discharge from the index hospitalization, participants will be followed for the duration of hospital stay, an expected average of 3 days.
Time frame: 3 days in average